BREAKING NEWS
First-ever NHS pilot of routine pharmacogenetic testing to guide drug choice in primary care will begin in early 2023 in north-west England, with plans for it to become a national programme if successful. Drugs include antidepressants, statins and proton pump inhibitors (PPIs).
Great move forward!
There are also plans to expand pharmacogenomic testing in Scotland, where health board NHS Tayside has begun a routine clopidogrel genotype testing service in secondary care after acute stroke, and there are also plans in development to use pharmacogenomic testing pilots more broadly using gene panels.
#pharmacogenetics #CYP2D6 #CYP2C19 #SLCO1B1
Joba van den Berg Ernst Kuipers
Great move forward!
There are also plans to expand pharmacogenomic testing in Scotland, where health board NHS Tayside has begun a routine clopidogrel genotype testing service in secondary care after acute stroke, and there are also plans in development to use pharmacogenomic testing pilots more broadly using gene panels.
#pharmacogenetics #CYP2D6 #CYP2C19 #SLCO1B1
Joba van den Berg Ernst Kuipers
No comments:
Post a Comment